Glomerulonefropati rapporteredes hos rotter efter 3- 5 gange større eksponering end det kliniske AUC efter 6 behandlingscykler med clofarabin.
Glomerulonephropathy was reported in rats at exposure levels 3 to 5 fold higher than the clinical AUC after 6 dosing cycles of clofarabine.